CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 36 enrolled
Drug / intervention
Midazolam, 2-5 mg IV + Glycopyrrolate, 0.1 mg IV + Ketamine, 10-20 mg + propofol as needed +4 moredrug
Likely dose
Popliteal block: 25 mL of 0.25% bupivacaine plus 2 mg dexamethasone; Adductor canal block: 10 mL of 0.25% bupivacaine plus 2 mg dexamethasone; Spinal: 45-60 mg of 1.5% mepivacaine; General anesthesia: LMA with propofol infusion, sevoflurane, and ketamine 10 mg/hrAI-extracted
Key inclusion· 5
  • Age 18-75 years
  • ASA Physical Status classification 1-3
  • Elective foot and ankle day surgery lasting 1-3 hours
  • Planned for combined popliteal and adductor canal block
Key exclusion· 14
  • Incapable of providing informed consent
  • Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site)
  • Anticipated difficult airway
  • BMI >40

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02996591
NCT02996591Phase 4Completed

Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery: A Double-Blinded Randomized Controlled Trial.

Hospital for Special Surgery, New York·interventional·Posted Dec 19, 2016·Updated Nov 12, 2019

In Brief

A Phase 4 clinical trial evaluating 25 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for popliteal nerve block, 10 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for adductor canal nerve block, and 3 other interventions for Nerve Block and 4 related conditions. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if there is a difference in patient outcomes with general anesthesia versus spinal anesthesia when given in addition to popliteal and adductor canal nerve blocks for foot and ankle surgery. Popliteal and adductor canal nerve blocks are injections of local anesthetic agents near nerves in the back and front of the knee going to the foot and ankle that provide numbness during and after surgery. These peripheral nerve blocks offer good pain control and reduce the need for opioids (opioids are pain medications such as morphine, Dilaudid, and oxycodone). General anesthesia involves the flow of oxygen and anesthesia gas through a tube which, along with additional intravenous medications, causes unconsciousness and unawareness of sensations during surgery. Spinal anesthesia involves an injection of local anesthetic in the lower back, which causes numbness below the waist. In addition to spinal anesthesia, a sedative is typically given intravenously to cause relaxation and sleepiness throughout surgery. General, spinal, and nerve block anesthesia are all routinely used for surgery at the Hospital for Special Surgery. General or spinal anesthesia is typically used in addition to peripheral nerve blocks during foot and ankle surgery to 1) allow the surgeons to use a thigh tourniquet to reduce bleeding, 2) provide anesthesia earlier, and 3) prevent unwanted movement. However, it is unclear whether general or spinal anesthesia provides better patient outcomes when given with peripheral nerve blocks. Some reports show that on its own, spinal anesthesia has advantages over general anesthesia in terms of side effects such as nausea and pain. However, these advantages may also be gained from combining peripheral nerve blocks with general anesthesia. Spinal anesthesia can be associated with headache and backache, although headache and backache can also happen after operations performed with general anesthesia. A previous study at the Hospital for Special Surgery showed low rates of nausea among patients who received nerve blocks with spinal anesthesia, and no nausea among patients who received a nerve block with general anesthesia. Therefore, the primary aim of this study is to determine if, as a treatment, either general or spinal anesthesia has advantages over the other treatment in terms of readiness for discharge, side effects, pain and patient satisfaction in an ambulatory foot and ankle population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedDec 19, 2016
Enrollment StartJan 1, 2017
Primary CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.5 years ago

Interventions

25 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for popliteal nerve blockprocedure

10 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for adductor canal nerve blockprocedure

Midazolam, 2-5 mg IV + Glycopyrrolate, 0.1 mg IV + Ketamine, 10-20 mg + propofol as neededdrug

45-60 mg of 1.5% mepivacaine for spinal anesthesiaprocedure

LMA insertion + titrated propofol infusion + sevoflurane + ketamine 10 mg/hr for general anesthesiaprocedure